From the Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany (P.M.D., A.V., S.L., M.M., F.W.M.); and Department of Cardiac Surgery, Columbia University, New York, NY (M.A.B.).
Circulation. 2015 Aug 25;132(8):731-40. doi: 10.1161/CIRCULATIONAHA.115.015279.
Current guidelines do not provide recommendations for optimal timing of coronary artery bypass surgery (CABG) in patients with non-ST-segment-elevation myocardial infarction. Our study aimed to determine the impact of CABG timing on early and late outcomes in patients with non-ST-segment-elevation myocardial infarction.
A total of 758 patients underwent CABG within 21 days after non-ST-segment-elevation myocardial infarction between January 2008 and December 2012 at our institution. The patients were divided into 3 groups according to the time interval between symptom onset and CABG: group A, <24 hours (133 patients); group B, 24 to 72 hours (192 patients); and group C, >72 hours to 21 days (433 patients). Predictors of in-hospital and long-term mortality were identified by logistic and Cox regression analyses, respectively. Overall in-hospital mortality was 5.1% (39 patients): 6.0%, 4.7%, and 5.1% in groups A, B, and C (P=0.9), respectively. A total of 118 patients died during follow-up. The 5-year survival was 73.1±2%, with a nonsignificant trend toward better survival in groups A (78.2±4%) and C (75.4±3%) compared with group B (63.6±5%; log-rank P=0.06). Renal insufficiency and LMD were independent predictors of in-hospital (odds ratio, 3.1; P=0.001; and odds ratio, 3.1; P=0.002) and long-term mortality (hazard ratio, 1.7; P=0.004; and hazard ratio, 1.5; P=0.02), whereas administration of P2Y12 inhibitors was protective (odds ratio, 0.3; P=0.01).
Emergent CABG within 24 hours of non-ST-segment-elevation myocardial infarction is associated with in-hospital mortality and long-term outcomes similar to those of CABG performed after 3 days, despite a higher risk profile. CABG performed between 24 to 72 hours showed a nonsignificant trend toward poorer long-term outcomes. Dual antiplatelet therapy until surgery is beneficial, whereas renal insufficiency and left main disease increase the risk of early and late death.
目前的指南并未为非 ST 段抬高型心肌梗死患者的冠状动脉旁路移植术(CABG)的最佳时机提供建议。我们的研究旨在确定非 ST 段抬高型心肌梗死患者 CABG 时机对早期和晚期结局的影响。
2008 年 1 月至 2012 年 12 月期间,我院共有 758 例非 ST 段抬高型心肌梗死后 21 天内行 CABG 患者。根据症状发作至 CABG 的时间间隔,患者分为 3 组:A 组,<24 小时(133 例);B 组,24 至 72 小时(192 例);C 组,>72 小时至 21 天(433 例)。通过逻辑回归和 Cox 回归分析分别确定住院和长期死亡率的预测因素。总体住院死亡率为 5.1%(39 例):A、B 和 C 组分别为 6.0%、4.7%和 5.1%(P=0.9)。随访期间共有 118 例患者死亡。5 年生存率为 73.1±2%,A 组(78.2±4%)和 C 组(75.4±3%)的生存率呈上升趋势,与 B 组(63.6±5%;log-rank P=0.06)相比,无统计学意义。肾功能不全和左主干病变是住院(优势比,3.1;P=0.001;和优势比,3.1;P=0.002)和长期死亡率(风险比,1.7;P=0.004;和风险比,1.5;P=0.02)的独立预测因素,而 P2Y12 抑制剂的应用具有保护作用(优势比,0.3;P=0.01)。
非 ST 段抬高型心肌梗死后 24 小时内行 CABG 与住院死亡率和长期结局相关,与 3 天后行 CABG 相似,尽管风险更高。24 至 72 小时内行 CABG 与长期结局呈轻微负相关。术前双重抗血小板治疗有益,而肾功能不全和左主干病变增加了早期和晚期死亡的风险。